Jie Jiang

Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

Antoni Hurtado, Kelly A. Holmes, Timothy R. Geistlinger et al. · Nature · 2008 · 315 citations · Full text

Breast Oncology, Oestrogen Receptor–pax2, Medicine +6

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

Andreas Polychronis, H D Sinnett, Dimitri Hadjiminas et al. · The Lancet Oncology · 2005 · 194 citations

Breast Oncology, Medicine, Gynecology +6

Transient Receptor Potential Melastatin 7–like Current in Human Head and Neck Carcinoma Cells: Role in Cell Proliferation

Jie Jiang, Minghua Li, Kōichi Inoue et al. · Cancer Research · 2007 · 134 citations · Full text

The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer

NC Wortham, Eliyaz Ahamed, Samantha M. Nicol et al. · Oncogene · 2009 · 110 citations · Full text

Tumor Biology, Transcriptional Regulation, Breast Oncology +12

Phosphorylation of ERα at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERα phosphorylation in breast cancer progression

Naveed Sarwar, J. S. Kim, Jie Jiang et al. · Endocrine Related Cancer · 2006 · 100 citations · Full text